$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE

21.02.25 18:30 Uhr

NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating bluebird bio, Inc. (Nasdaq: BLUE), relating to the proposed merger with Beacon Parent Holdings, L.P. Under the terms of the agreement, bluebird stockholders will receive $3.00 per share and a contingent value right per share of $6.84 in cash if bluebird's current product portfolio achieves $600 million in net sales in a 12-month period before December 31, 2027.

Click here for more https://monteverdelaw.com/case/bluebird-bio-inc-blue/. It is free and there is no cost or obligation to you.

Monteverde & Associates PC Logo

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  • Do you file class actions and go to Court?
  • When was the last time you recovered money for shareholders?
  • What cases did you recover money in and how much?
  • About Monteverde & Associates PC

    Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

    No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

    Contact:
    Juan Monteverde, Esq.
    MONTEVERDE & ASSOCIATES PC
    The Empire State Building
    350 Fifth Ave. Suite 4740
    New York, NY 10118
    United States of America
    jmonteverde@monteverdelaw.com
    Tel: (212) 971-1341

    Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-of-bluebird-bio-inc--blue-302382464.html

    SOURCE Monteverde & Associates PC

    In eigener Sache

    Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

    Nachrichten zu bluebird bio Inc

    Wer­bung

    Analysen zu bluebird bio Inc

    DatumRatingAnalyst
    18.06.2019bluebird bio BuyMaxim Group
    22.02.2019bluebird bio NeutralCantor Fitzgerald
    02.11.2018bluebird bio NeutralCantor Fitzgerald
    12.07.2018bluebird bio BuyGabelli & Co
    22.02.2018bluebird bio UnderweightCantor Fitzgerald
    DatumRatingAnalyst
    18.06.2019bluebird bio BuyMaxim Group
    12.07.2018bluebird bio BuyGabelli & Co
    13.12.2017bluebird bio OverweightBarclays Capital
    05.12.2017bluebird bio BuyCanaccord Adams
    30.11.2017bluebird bio BuyMaxim Group
    DatumRatingAnalyst
    22.02.2019bluebird bio NeutralCantor Fitzgerald
    02.11.2018bluebird bio NeutralCantor Fitzgerald
    21.12.2017bluebird bio PerformOppenheimer & Co. Inc.
    13.12.2017bluebird bio HoldMaxim Group
    30.06.2017bluebird bio NeutralBTIG Research
    DatumRatingAnalyst
    22.02.2018bluebird bio UnderweightCantor Fitzgerald
    11.12.2017bluebird bio UnderweightCantor Fitzgerald
    16.06.2017bluebird bio ReduceStandpoint Research
    14.10.2016bluebird bio SellCantor Fitzgerald

    Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für bluebird bio Inc nach folgenden Kriterien zu filtern.

    Alle: Alle Empfehlungen

    Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
    Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
    Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
    mehr Analysen